About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Milestone Pharmaceuticals Inc. - Common Shares (NQ:MIST)

2.035 -0.045 (-2.16%)

Streaming Delayed Price Updated: 9:34 AM EST, Dec 29, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Milestone Pharmaceuticals Inc. - Common Shares

< Previous 1 2 3 Next >

Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket ↗

February 29, 2024

Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 29, 2024

It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning!

Via InvestorPlace

Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 26, 2024

Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.

Via Benzinga

Why Milestone Pharmaceuticals (MIST) Stock Is Rising ↗

February 26, 2024

Milestone Pharmaceuticals shares are trading higher by 19.4% Monday morning. The company announced plans to resubmit the NDA for etripamil to the FDA.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 26, 2024

Via Benzinga

MILESTONE ALERT: Bragar Eagel & Squire, P.C. is Investigating Milestone Pharmaceuticals Inc. on Behalf of Milestone Stockholders and Encourages Investors to Contact the Firm

January 18, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – MIST

January 06, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Recap: Milestone Pharmaceuticals Q3 Earnings ↗

November 13, 2023

Via Benzinga

Analyst Expectations for Milestone Pharmaceuticals's Future ↗

June 20, 2023

Via Benzinga

Expert Ratings for Milestone Pharmaceuticals ↗

May 23, 2023

Via Benzinga

Milestone Pharmaceuticals: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

Milestone Pharmaceuticals's Return On Capital Employed Overview ↗

March 30, 2023

Via Benzinga

ROSEN, A LONGSTANDING LAW FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - MIST

January 04, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January ↗

January 02, 2024

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – MIST

January 01, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

ROSEN, A LEADING AND RANKED FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - MIST

December 31, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Meta To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

December 27, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher ↗

December 26, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.50% to 37,574.66 while the NASDAQ rose 0.50% to 15,068.50. The...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 26, 2023

Via Benzinga

Crude Oil Rises Over 3%; US Home Prices Increase In October ↗

December 26, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday. The Dow traded up 0.34% to 37,511.87 while the NASDAQ rose 0.43% to 15,057.13. The...

Via Benzinga

Topics Stocks

Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 26, 2023

Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth...

Via Benzinga

ROSEN, A LEADING LAW FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – MIST

December 26, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

Why Is Heart Disease-Focused Milestone Pharmaceuticals Stock Plummeting Today? ↗

December 26, 2023

Milestone Pharmaceuticals Inc (NASDAQ: MIST) announced Tuesday that the Company received a Refusal to File (RTF) letter from the FDA for the New Drug Application seeking approval for self-administered...

Via Benzinga

Dow Gains Over 50 Points; Chicago Fed National Activity Index Increases For November ↗

December 26, 2023

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.09% to 37,418.31 while the NASDAQ rose...

Via Benzinga

Topics Economy Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 26, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 19, 2023

Via Benzinga

Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 28, 2023

Gainers

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023 ↗

June 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 05, 2022

Via Benzinga

Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday ↗

October 18, 2022

Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Milestone Pharmaceuticals Inc. - Common Shares (NQ:MIST)

All News about Milestone Pharmaceuticals Inc. - Common Shares

Sections

Services

Contact Information

Follow Us